Analyst Ratings for ResMed (RMD)
RMD Rating Summary
RMD Price Target Summary
- Highest: $300.00 (UBS)
- Lowest: $180.00 (Wolfe Research)
- Average: $236.42
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$236.42 (-1.1%)
* Over Last 12-Mos
Rating Score: 4.6 / 10
Percentile Rank: 46%
Rating Score: 4.6 / 10
Percentile Rank: 46%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/15/2026 | RBC Capital | Craig Wong-Pan | Upgrade | Outperform (Sector Perform) |
262.00 (244.00) |
218.27 (238.97) |
9.48% | Details |
| 8/19/2026 | Rothschild Redburn | Jackson Philips | New Coverage | Neutral (N/A) |
230.00 (N/A) |
220.37 (238.97) |
8.44% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
